GLOFITAMAB

2383 reported adverse events

Drug classes: Bispecific CD20-directed CD3 T Cell Engager [EPC]

These side effects are most commonly reported by patients taking GLOFITAMAB:

# Side effect Count
0 CYTOKINE RELEASE SYNDROME 747
1 DISEASE PROGRESSION 444
2 DEATH 282
3 OFF LABEL USE 280
4 PYREXIA 194
5 NEUTROPENIA 185
6 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 143
7 COVID-19 115
8 FEBRILE NEUTROPENIA 103
9 INFECTION 99
See all common reactions for GLOFITAMAB